Assessing Royalty Pharma (RPRX) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
Royalty Pharma plc - Class A Ordinary Shares (RPRX)
US:NASDAQ Investor Relations:
ir.reprosrx.com/investor-relations
Company Research
Source: Yahoo! Finance
Royalty Pharma stock triggered by performance data Royalty Pharma (RPRX) has attracted attention after recent performance data showed a 0.2% 1 day move, with returns of 4.8% over the past week and about 7% over the past month. See our latest analysis for Royalty Pharma. Royalty Pharma's recent momentum has been building, with a 90 day share price return of 22.5% and a 1 year total shareholder return of 59.8% from a latest share price of $48.57. If this kind of move has you looking for more ideas in healthcare, it could be a good moment to scan opportunities in 36 healthcare AI stocks With Royalty Pharma posting strong recent returns and trading at an intrinsic discount figure of 74.95%, the key question for you is whether the shares are still undervalued or if the market is already pricing in future growth. Most Popular Narrative: 5.8% Undervalued Royalty Pharma's latest close of $48.57 sits below the narrative fair value of $51.56, framing a modest discount that hinges
Show less
Read more
Impact Snapshot
Event Time:
RPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPRX alerts
High impacting Royalty Pharma plc - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
RPRX
News
- 1 Value Stock for Long-Term Investors and 2 Facing Challenges [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal [Yahoo! Finance]Yahoo! Finance
- 1 Cash-Producing Stock to Own for Decades and 2 That Underwhelm [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma and J&J partner to develop autoimmune treatment [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated DiseasesGlobeNewswire
RPRX
Sec Filings
- 4/2/26 - Form 4
- 4/1/26 - Form 144
- 4/1/26 - Form 13F-NT
- RPRX's page on the SEC website